CEFILAB-O

About

Cefilab-O is a combination antibiotic containing Cefixime and Ofloxacin. Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis and death. It is effective against a wide range of Gram-positive and Gram-negative bacteria. Ofloxacin is a fluoroquinolone antibiotic that acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. This dual mechanism of action provides a broad spectrum of antibacterial activity.

This combination therapy is particularly useful in treating mixed bacterial infections or infections where resistance to a single antibiotic is a concern. It offers enhanced efficacy against various pathogens, making it a potent option for complicated infections. The synergistic effect of these two antibiotics helps to overcome bacterial resistance and achieve better clinical outcomes in susceptible infections.

Uses

• Treatment of complicated urinary tract infections.
• Management of respiratory tract infections.
• Therapy for gynecological infections.
• Treatment of skin and soft tissue infections.

Directions For Use

Take this medication orally as prescribed by your doctor, usually with or without food. Complete the full course of treatment even if symptoms improve.

Benefits

• Broad spectrum antibacterial activity.
• Effective against resistant bacterial strains.
• Dual mechanism of action for enhanced efficacy.
• Convenient oral administration.
• Treats a wide range of bacterial infections.
• Helps prevent development of antibiotic resistance.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Insomnia
• Rash
• Taste disturbance
• Photosensitivity
• Vaginitis
• Elevated liver enzymes

Safety Measures

• Alcohol - While there is no direct interaction, alcohol consumption may exacerbate gastrointestinal side effects like nausea or dizziness. It is generally advisable to avoid or limit alcohol during antibiotic treatment.
• Pregnancy - Cefixime is generally considered safer than Ofloxacin during pregnancy, but the combination is usually avoided unless clearly necessary. Ofloxacin is generally contraindicated due to potential effects on fetal cartilage development. Consult a doctor.
• Breastfeeding - Both Cefixime and Ofloxacin can pass into breast milk. Ofloxacin is generally not recommended during breastfeeding due to potential risks to the infant. Consult a healthcare professional.
• Liver - Use with caution in patients with liver impairment. Both components are metabolized by the liver to some extent, and dose adjustments may be required. Monitor liver function tests.
• Kidney - Dose adjustment is necessary in patients with renal impairment as both Cefixime and Ofloxacin are primarily excreted by the kidneys. Close monitoring of kidney function is crucial.
• Lung - Fluoroquinolones like Ofloxacin can rarely cause exacerbation of myasthenia gravis, which can affect respiratory muscles. Use with caution in patients with pre-existing lung conditions or myasthenia gravis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.